FDA Investigator James W Whitney
James W Whitney has inspections in 15 countries as of 02 Nov 2023. James W Whitney has collaborated with a combined 3227 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
169
Last Inspection Date:
02 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
France,
Netherlands,
Mexico,
United Kingdom of Great Britain and Northern Ireland,
Sweden,
Canada,
Germany,
Switzerland,
China,
Poland,
Hungary,
Taiwan,
Belgium,
Ireland
Co-Investigator(s):
A Williams,
Aaron L Morris,
Abby E Pelletier,
Adaliz Santaliz Cruz,
Ademola O Daramola,
Alan R Condon,
Alice C Silva,
Alois P Provost,
Amanda Dinaro,
Amber G Wardwell,
Amy C Jordan,
Amy M Cramer,
Ana L Kewes,
Angela J Davis,
Annet R Rajan,
Anthony N Onianwa,
Arie C Menachem,
Benjamin J Dastoli,
Bradford L Swanson,
Brenda P King,
Burnell M Henry,
Camerson E Moore,
Catherine J Laufmann,
Christian D Lynch (CDL),
Christina D Lynch,
Christopher J Cruciotti,
Constance Desimone,
Crystal Nevins,
Cynthia L Gorveatt,
Daniel J Lahar,
Daniel L Aisen,
Darin S Wiegers,
Daryl A Dewoskin,
David C Sullivan,
David J Feria,
David P Vanhouten,
David Van Houten,
Dawn M Braswell,
Dennis R Hock,
Diane M Biron,
Dominic R Frasca,
Dorothy W Lee,
Edmund F Mrak, Jr,
Edward J Janik,
Elias N Paz Alonzo,
Elizabeth B Griffin,
Elizabeth D Connell,
Ellen P Madigan,
Emir Galevi,
Eric C Schmitt,
Eric M Padgett,
Erik W Koester,
Felix J Marrero,
Gale E Ryan,
Garry H Stewart,
Gary J Hagan,
Gary L Zaharek,
Gene D Arcy,
George T Allen, Jr,
Gerard D Difiore,
Gregson A Joseph,
Guozhou Mo,
Harperd,
Helen B Ricalde,
Hugh M Mcclure, II,
Ian A Pilcher,
Iris C Macinnes,
Jacqueline Mdiaz Albertini,
James A Lane,
James C Maclaughlin,
James D Hildreth,
James D Planchon,
James H Tanner,
James P Finn,
James R Montero,
Janete F Guardia,
Jason A Rossi,
Jason B Prosser,
Jeffrey J Thibodeau,
Jeffrey R Alling,
Jesse A Vazquez,
Jessica Hankins, PhD,
Jocelyn C Turner,
John A Sciacchitano,
John E Emmert,
John M Seale,
John P Shelton,
John S Hartford,
Jonah S Ufferfilge,
Jonathan B Lewis,
Jonathan G Matrisciano,
Justine M Corson,
Kalkidan A Molla,
Karen Mcnabb Noon,
Katarzyna Plona,
Kent A Conforti,
Kristina J Donohue,
Kristina M Joyce,
Kwong P Lee,
Laurie B Frazier,
LCDR Debra Emerson,
Lindsey Brown, PhD,
Lisa B Orr,
Lisa D Cash,
Lori A Holmquist,
Lorna F Jones,
Louis Christy,
Maida Henesian (NMI),
Marcia M Laughrey,
Margaret E Walsh,
Margaret M Sands,
Maribeth G Niesen,
Mark K Tseng,
Marlene L Davis,
Martin J Guardia,
Mary E Storch,
Maryam Tabatabaie,
Matthew C Watson,
Matthew J Sienko,
Maura Rooney,
Meihong Liu,
Melanie G Warzala,
Melanie W Pishnery,
Miaja Umaedi,
Michael E Marcarelli,
Michael G Mayfield,
Michael G Sinkevich,
Michael J Leal,
Michael K Larson,
Michael L Chasey,
Michael P Sweeney,
Michelle J Glembin,
Michelle M Noe,
Mihaly S Ligmond,
Msdap Gonzlezk,
Mutahar S Shamsi,
Nabil Nakhoul,
Nassim Ben Makhlouf,
Natasha N Mccants,
Omotunde O Osunsanmi,
Parul M Patel,
Patricia A Mcilroy,
Paul A Bonneau,
Paul E Stein,
Paul P Geraci,
Paula A Trost,
Paula M Laplant,
Philip H Lafleur,
Ramon E Martinez,
Richard Jay Tucker, RS,
Richard K Vogel,
Richard T Riggie,
Robert J Martin,
Ronald T Weber,
Rosanna M Goodrich,
Rose M Ashley,
Saleem A Akhtar,
Sandra P White,
Sara M Onyango,
Scott A Nabe,
Sean R Marcsisin,
Seth A Mailhot,
Sherri N Rohlf, MD,
Stacey S Degarmo,
Stanley B Eugene, BS, BME,
Stephen C Smith,
Stephen D Eich,
Sunita Pandey,
Susanne M Richardson, MSc RAC ELS,
Suzanne M Healy,
Tamara S Rosbury,
Tara C Alcazar,
Terry C Kimball,
Thanh M Andrews,
Thomas A Peter,
Thomas W Gordon,
Thuy T Nguyen, LCDR,
Viviana Matta,
Wanda J Torres,
Wayne E Seifert,
Wendy M Stone,
William K Dagley,
William S Boivin,
Yasamin Ameri,
Youmin Wang
James W Whitney's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more